GSK Consumer Healthcare, of Warren, N.J. recalls
1 recall recorded since 2018, most recently on 23 December 2020. Status and classification are as published by the CPSC.
Recalls1
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 23 December 2020
- Reason
- Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).
- Remedy
- Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.
- Recall number
- 21057
- Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.